Horizon Pharma, Inc. (Nasdaq:HZNP) and Vidara Therapeutics International Ltd. (Vidara) announced they have entered into a definitive agreement under which Horizon Pharma will acquire Vidara through a reverse merger for stock and cash valued at approximately $660 million. Horizon Pharma plc will be the name of the resulting company. Horizon Pharma Inc (NASDAQ:HZNP) shares after opening at $18.00 moved to $18.30 on last trade day and at the end of the day closed at $16.02. Company price to sales ratio in past twelve months was calculated as 19.04 and price to cash ratio as 17.64. Horizon Pharma Inc (NASDAQ:HZNP) showed a positive weekly performance of 17.62%.
TherapeuticsMD, Inc. (NYSEMKT:TXMD) announced the launch of vitaPearl, thelatest addition to the vitaMedMD prenatal multivitamin line. vitaPearl is currently the smallest completeprescription prenatal multivitamin on the market. TherapeuticsMD Inc (NYSEMKT:TXMD) shares fell -7.40% in last trading session and ended the day on $7.38. TherapeuticsMD Inc (NYSEMKT:TXMD) return on equity ratio is recorded as -71.50% and its return on assets is -64.10%. TherapeuticsMD Inc (NYSEMKT:TXMD) yearly performance is 334.12%.
Investment analysts at Stifel Nicolaus lifted their price target on shares of Aerie Pharmaceuticals (NASDAQ:AERI) from $22.00 to $24.00 in a note issued to investors on Wednesday, Analyst Ratings Network reports. The firm currently has a “buy” rating on the stock. Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) shares moved up 8.41% in last trading session and was closed at $23.73, while trading in range of $21.50 – $23.97. Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) year to date (YTD) performance is 32.13%.
Novogen Limited (ADR) (NASDAQ:NVGN) and its joint venture company with Yale University, CanTx Inc, announced an important milestone with lead candidate drug, Trx-1, demonstrating a potent anti-cancer effect in mice xenografted with human ovarian cancer stem cells. Novogen Limited (ADR) (NASDAQ:NVGN) weekly performance is -0.46%. On last trading day company shares ended up $4.30. Novogen Limited (ADR) (NASDAQ:NVGN) distance from 50-day simple moving average (SMA50) is 0.76%.